Tekla Life Valuation
| HQL Stock | USD 16.96 0.10 0.59% |
At this time, the company appears to be fairly valued. Tekla Life Sciences has a current Real Value of $16.76 per share. The regular price of the company is $16.96. Our model measures the value of Tekla Life Sciences from inspecting the company fundamentals such as Shares Outstanding of 29.6 M, return on equity of 0.18, and Operating Margin of (3.47) % as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Tekla Life's price fluctuation is very steady at this time. Calculation of the real value of Tekla Life Sciences is based on 3 months time horizon. Increasing Tekla Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Tekla stock is determined by what a typical buyer is willing to pay for full or partial control of Tekla Life Sciences. Since Tekla Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tekla Stock. However, Tekla Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.96 | Real 16.76 | Hype 16.95 | Naive 16.9 |
The intrinsic value of Tekla Life's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Tekla Life's stock price.
Estimating the potential upside or downside of Tekla Life Sciences helps investors to forecast how Tekla stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tekla Life more accurately as focusing exclusively on Tekla Life's fundamentals will not take into account other important factors: About Tekla Life Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Tekla Life Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Tekla Life Sciences based exclusively on its fundamental and basic technical indicators. By analyzing Tekla Life's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Tekla Life's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tekla Life. We calculate exposure to Tekla Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tekla Life's related companies.Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Tekla Life operates under Asset Management classification in the United States and is traded on New York Stock Exchange.
A single share of Tekla Life represents a small ownership stake in the entity. As a stockholder of Tekla, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Tekla Life Dividends Analysis For Valuation
There are various types of dividends Tekla Life can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Tekla shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Tekla Life Sciences directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Tekla pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Tekla Life by the value of the dividends paid out.
Tekla Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as Tekla Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 28.9 M | |
| Quarterly Earnings Growth Y O Y | 2.594 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. Market participants price Tekla higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Tekla Life assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Tekla Life Sciences's market price often diverges from its book value, the accounting figure shown on Tekla's balance sheet. Smart investors calculate Tekla Life's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Tekla Life's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.